search
Back to results

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study (HEALTHH)

Primary Purpose

Tobacco Dependence

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tobacco/Physical Activity Intervention
Diet plus BP/CHOL Intervention
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tobacco Dependence focused on measuring Tobacco dependence, Cardiovascular disease, Risk behaviors, Smoking, Physical activity, Alaska Native people

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Smoking > 5 cigarettes/day and > 100 cigarettes in one's lifetime
  • Hypertension, hypercholesterolemia, or established vascular disease
  • Fluent in English language

Exclusion Criteria:

  • Dementia or other brain injury
  • Pregnancy or breastfeeding
  • Currently engaged in tobacco treatment or using cessation pharmacotherapy

Sites / Locations

  • Norton Sound Health Corporation
  • Stanford Hospital and Clinics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Tobacco/Physical Activity Intervention

Diet plus BP/CHOL Intervention

Arm Description

Includes a psychosocial component that utilizes a counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for tobacco and physical activity, adherence with nicotine replacement therapy, and self-monitoring with a pedometer-based walking program. The intervention will provide 12 weeks of nicotine replacement therapy for participants.

Consists of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for managing hypertension and hypercholesterolemia, and adherence with antihypertensives and statins with supportive dietary changes. The intervention provides a cookbook of heart healthy regional recipes and medication bag for storing medications.

Outcomes

Primary Outcome Measures

Smoking Status: 7-day point prevalence abstinence
Change from baseline as no tobacco use, including a puff, in the past 7 days

Secondary Outcome Measures

Minutes of moderate-to-vigorous physical activity in past 7 days
self-reported minutes of moderate-to-vigorous physical activity
Blood pressure
Measured as systolic/diastolic in mmHg
Total, LDL, and HDL cholesterol
measured in milligrams per deciliter of blood (mg/dL)
Body Mass Index (BMI)
weight (in kilograms) over height squared (in centimeters)
Framingham Risk Factor Score
gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual
Medication Adherence
self-reported assessment of adherence to BP and CHOL meds
Dietary Quality
culturally tailored FFQ assessing consumption of native and non-native foods
Multiple Risk Behavior Change Impact Factor
intervention efficacy times participation summed over the multiple behavioral targets, I = ∑# of behaviors(n) (En × Pn)
Linear index of multiple behavior change
computed by subtracting baseline scores from follow-up scores for each risk behavior, dividing by the standard deviation of the difference (i.e., z-score), and summing across the individual risks (smoking, exercise, diet, adherence)

Full Information

First Posted
May 12, 2014
Last Updated
January 28, 2022
Sponsor
Stanford University
Collaborators
University of California, San Francisco, Alaska Native Tribal Health Consortium, University of Alaska Anchorage, Norton Sound Health Corporation, National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT02137902
Brief Title
Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study
Acronym
HEALTHH
Official Title
Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
June 1, 2015 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
University of California, San Francisco, Alaska Native Tribal Health Consortium, University of Alaska Anchorage, Norton Sound Health Corporation, National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to identify effective and cost-effective interventions for tobacco use and other risk behaviors for cardiovascular disease among Alaska Native people in rural villages. In a randomized controlled trial, the study will compare interventions using telemedicine to promote the American Heart Association's identified ideal health behaviors (nonsmoking and physical activity) relative to ideal health factors (managing cholesterol and blood pressure).
Detailed Description
In an RCT, we will compare 2 active treatments delivered over 12-months via telehealth services linking participants in rural villages to Anchorage and Stanford-based study counselors overcoming access-to-care for CV preventive health issues. The village AN health aides will facilitate data collection and telehealth connectivity. Intervention contacts occur at baseline, 3-, 6- and 12-months follow-up, with the final assessment at 18-months. The repeated intervention contacts provide iterative computerized feedback reflecting prior responses and encouragement of adoption and maintenance of behavioral health goals. The groups are: Tobacco/Physical Activity Intervention (n=150), consisting of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program. The study will provide 12-weeks of NRT for participants randomized to this intervention condition. HTN/HCL (HTN/HC, n=150), consisting of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. The AN health plan covers antihypertensive and statins as a benefit to patients and would be prescribed as part of standard of care (i.e., not prescribed for the purposes of this research); however, strategies to maximize medication adherence are needed, hence the focus of this intervention. The counseling and print materials are highly individualized, unique to the participant, thereby minimizing the likelihood of cross-condition contamination, determined to be minimal in prior investigations. For the research study, participant eligibility criteria include AN heritage; daily cigarette smoking; and hypertension, hyperlipidemia, or established vascular disease. Intention to change the targeted risk behaviors will not be required to participate. Utilizing telemedicine technology and Transtheoretical Model-tailored interventions, the trial aims to reach at-risk AN people regardless of residential location or current motivation. The primary outcome is biochemically-confirmed tobacco abstinence using anabasine. Secondary outcomes include moderate-to-vigorous physical activity assessed by self-report, blood pressure, cholesterol ratio, medication adherence, dietary change, body mass index, Framingham index, multibehavioral impact factor, a linear index, and cost effectiveness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tobacco Dependence
Keywords
Tobacco dependence, Cardiovascular disease, Risk behaviors, Smoking, Physical activity, Alaska Native people

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
299 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tobacco/Physical Activity Intervention
Arm Type
Experimental
Arm Description
Includes a psychosocial component that utilizes a counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for tobacco and physical activity, adherence with nicotine replacement therapy, and self-monitoring with a pedometer-based walking program. The intervention will provide 12 weeks of nicotine replacement therapy for participants.
Arm Title
Diet plus BP/CHOL Intervention
Arm Type
Experimental
Arm Description
Consists of a psychosocial component that includes counselor-facing computer-assisted intervention with tailored counseling feedback focused on increasing intrinsic motivation, goal setting for managing hypertension and hypercholesterolemia, and adherence with antihypertensives and statins with supportive dietary changes. The intervention provides a cookbook of heart healthy regional recipes and medication bag for storing medications.
Intervention Type
Behavioral
Intervention Name(s)
Tobacco/Physical Activity Intervention
Intervention Description
Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation and goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program.
Intervention Type
Behavioral
Intervention Name(s)
Diet plus BP/CHOL Intervention
Intervention Description
Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. Includes a native diet cookbook and medication bag.
Primary Outcome Measure Information:
Title
Smoking Status: 7-day point prevalence abstinence
Description
Change from baseline as no tobacco use, including a puff, in the past 7 days
Time Frame
Assessed at baseline, 3, 6, 12, and 18 months
Secondary Outcome Measure Information:
Title
Minutes of moderate-to-vigorous physical activity in past 7 days
Description
self-reported minutes of moderate-to-vigorous physical activity
Time Frame
Assessed at baseline, 3, 6, 12, and 18 months
Title
Blood pressure
Description
Measured as systolic/diastolic in mmHg
Time Frame
Assessed at baseline, 3, 6, 12, and 18 months
Title
Total, LDL, and HDL cholesterol
Description
measured in milligrams per deciliter of blood (mg/dL)
Time Frame
Assessed at baseline and 18 months
Title
Body Mass Index (BMI)
Description
weight (in kilograms) over height squared (in centimeters)
Time Frame
Assessed at baseline, 3, 6, 12, and 18 months
Title
Framingham Risk Factor Score
Description
gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual
Time Frame
Assessed at baseline and 18 months
Title
Medication Adherence
Description
self-reported assessment of adherence to BP and CHOL meds
Time Frame
Assessed at baseline, 3, 6, 12 and 18 months
Title
Dietary Quality
Description
culturally tailored FFQ assessing consumption of native and non-native foods
Time Frame
Assessed at baseline, 3, 6, 12 and 18 months
Title
Multiple Risk Behavior Change Impact Factor
Description
intervention efficacy times participation summed over the multiple behavioral targets, I = ∑# of behaviors(n) (En × Pn)
Time Frame
Assessed at baseline, 3, 6, 12 and 18 months
Title
Linear index of multiple behavior change
Description
computed by subtracting baseline scores from follow-up scores for each risk behavior, dividing by the standard deviation of the difference (i.e., z-score), and summing across the individual risks (smoking, exercise, diet, adherence)
Time Frame
Assessed at baseline, 3, 6, 12 and 18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Smoking > 5 cigarettes/day and > 100 cigarettes in one's lifetime Hypertension, hypercholesterolemia, or established vascular disease Fluent in English language Exclusion Criteria: Dementia or other brain injury Pregnancy or breastfeeding Currently engaged in tobacco treatment or using cessation pharmacotherapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Judith J Prochaska, PhD, MPH
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Norton Sound Health Corporation
City
Nome
State/Province
Alaska
ZIP/Postal Code
99762
Country
United States
Facility Name
Stanford Hospital and Clinics
City
Stanford
State/Province
California
ZIP/Postal Code
94304
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26332005
Citation
Prochaska JJ, Benowitz NL. The Past, Present, and Future of Nicotine Addiction Therapy. Annu Rev Med. 2016;67:467-86. doi: 10.1146/annurev-med-111314-033712. Epub 2015 Aug 26.
Results Reference
background
PubMed Identifier
26196657
Citation
Prochaska JJ, Benowitz NL. Smoking cessation and the cardiovascular patient. Curr Opin Cardiol. 2015 Sep;30(5):506-11. doi: 10.1097/HCO.0000000000000204.
Results Reference
background
PubMed Identifier
29864548
Citation
Prochaska JJ, Epperson A, Skan J, Oppezzo M, Barnett P, Delucchi K, Schnellbaecher M, Benowitz NL. The Healing and Empowering Alaskan Lives Toward Healthy-Hearts (HEALTHH) Project: Study protocol for a randomized controlled trial of an intervention for tobacco use and other cardiovascular risk behaviors for Alaska Native People. Contemp Clin Trials. 2018 Aug;71:40-46. doi: 10.1016/j.cct.2018.06.003. Epub 2018 Jun 2.
Results Reference
derived

Learn more about this trial

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study

We'll reach out to this number within 24 hrs